Advances in the prognostication and management of advanced MDS in children
Authors:
Open Access
- 9 May 2011
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 154 (2) , 185-195
Abstract
Summary: Advanced myelodysplastic syndrome (MDS) in children includes refractory anaemia with excess blasts (RAEB) and RAEB in transformation (RAEB‐T) according to the paediatric modification of the World Health Organization classification. Clinical features and cytogenetics are essential to make a diagnosis because blast count alone is insufficient to differentiate MDS from acute myeloid leukaemia (AML). Little is known about molecular genetics in paediatric MDS but hypermethylation seem to be frequent. Monosomy 7 is the most common cytogenetic aberration but prognostic neutral whereas those with structural complex karyotype have a very poor outcome. Haematopoietic stem cell transplantation (HSCT) is the treatment of choice and results in cure rates of around 60%. Intensive chemotherapy prior to HSCT provides no survival benefit for children with RAEB and RAEB‐T and can generally not be recommended. Intensive chemotherapy before HSCT should be considered in patients with myelodysplasia‐related‐AML (MDR‐AML).Keywords
This publication has 95 references indexed in Scilit:
- Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantationLeukemia, 2010
- Stable long‐term risk of leukaemia in patients with severe congenital neutropenia maintained on G‐CSF therapyBritish Journal of Haematology, 2010
- Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort studyBritish Journal of Haematology, 2010
- Telomere DiseasesNew England Journal of Medicine, 2009
- Mutation inTET2in Myeloid CancersNew England Journal of Medicine, 2009
- Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conferenceBritish Journal of Haematology, 2008
- Syndromic thrombocytopenia and predisposition to acute myelogenous leukemia caused by constitutional microdeletions on chromosome 21qBlood, 2008
- Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic disordersBlood, 2007
- Myelodysplastic syndrome associated with monosomy 7 in childhood: a retrospective studyCancer Genetics and Cytogenetics, 2006
- Low frequency of NRAS and KRAS2 gene mutations in childhood myelodysplastic syndromesCancer Genetics and Cytogenetics, 2004